Page last updated: 2024-10-24

chelerythrine and Disease Exacerbation

chelerythrine has been researched along with Disease Exacerbation in 2 studies

chelerythrine : A benzophenanthridine alkaloid isolated from the root of Zanthoxylum simulans, Chelidonium majus L., and other Papaveraceae.

Research Excerpts

ExcerptRelevanceReference
"To investigate whether a protein kinase C (PKC) inhibitor and melatonin prevent proliferative vitreoretinopathy (PVR)."7.73Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin. ( Er, H; Mizrak, B; Parlakpinar, H; Turkoz, Y, 2006)
"To investigate whether a protein kinase C (PKC) inhibitor and melatonin prevent proliferative vitreoretinopathy (PVR)."3.73Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin. ( Er, H; Mizrak, B; Parlakpinar, H; Turkoz, Y, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Zhu, M1
Niu, J1
Jiang, J1
Dong, T1
Chen, Y1
Yang, X1
Liu, P1
Er, H1
Turkoz, Y1
Mizrak, B1
Parlakpinar, H1

Other Studies

2 other studies available for chelerythrine and Disease Exacerbation

ArticleYear
Chelerythrine inhibits the progression of glioblastoma by suppressing the TGFB1-ERK1/2/Smad2/3-Snail/ZEB1 signaling pathway.
    Life sciences, 2022, Mar-15, Volume: 293

    Topics: Animals; Antineoplastic Agents; Benzophenanthridines; Brain Neoplasms; Cell Line, Tumor; Cell Surviv

2022
Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2006, Volume: 220, Issue:1

    Topics: Alkaloids; Animals; Benzophenanthridines; Disease Models, Animal; Disease Progression; Drug Therapy,

2006